Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.915
+0.025 (0.51%)
At close: Aug 13, 2025, 4:00 PM
4.910
-0.005 (-0.10%)
After-hours: Aug 13, 2025, 4:20 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $623.51 million as of August 13, 2025. Its market cap has increased by 53.69% in one year.
Market Cap
623.51M
Enterprise Value
590.61M
1-Year Change
53.69%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $623.51M, an increase of 65.56%. That is a compound annual growth rate of 6.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 622.90M | 46.84% |
| Dec 31, 2024 | 424.20M | -21.44% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 576.52B |
| Johnson & Johnson | 418.74B |
| AbbVie | 348.08B |
| UnitedHealth Group | 231.87B |
| Abbott Laboratories | 229.36B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |